Cargando…
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy
Neurologists are interested in understanding whether patients with multiple sclerosis (pwMS) undergoing immunomodulatory/immunosuppressive therapy are more susceptible to developing COVID-19 or have worse outcomes. Currently, there are no conclusive data in this regard. We report the prevalence and...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335234/ https://www.ncbi.nlm.nih.gov/pubmed/32650121 http://dx.doi.org/10.1016/j.msard.2020.102372 |